Protein microarrays as an application for disease biomarkers

被引:18
作者
Caiazzo, Robert J., Jr. [1 ]
Maher, Andrew J. [1 ]
Drummond, Michael P. [2 ]
Lander, Corey I. [2 ]
Tassinari, Oliver W. [1 ]
Nelson, Bryce P. [3 ]
Liu, Brian C. -S. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Urol,Mol Urol Lab, Boston, MA 02115 USA
[2] Wentworth Inst Technol, Dept Comp Sci & Syst, Boston, MA USA
[3] Gentel Biosci Inc, Madison, WI USA
基金
美国国家卫生研究院;
关键词
Autoantibody microarrays; Bioinformatics; Forward-phase microarrays; Multiplex; Reverse-phase microarrays; CAPTURE AUTOANTIBODY MICROARRAY; HUMORAL IMMUNE-RESPONSE; PROSTATE-CANCER; OVARIAN-CANCER; ANTIBODY ARRAYS; ANTIGEN; PROGRESSION; DISCOVERY; PATHWAYS; PLATFORM;
D O I
10.1002/prca.200800149
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein microarrays are an increasingly powerful technology in the hunt for new and novel diagnostic and prognostic biomarkers. Lending credit to the highly established DNA microarray, protein microarrays are versatile tools that utilize a variety of formats to facilitate the discovery of new biomarkers and our understanding of disease pathways. The aims of this review are: to detail a variety of protein microarray technologies currently used, including forward-phase technologies and reverse-phase technologies useful in both the discovery and validation of candidate biomarkers; to explore the strengths and weaknesses of various proteomic microarray platforms; to explain how bioinformatics helps compare data between microarray data sets; and to discuss the downstream applications of such technologies as they relate to the development of a highly personalized approach to medicine.
引用
收藏
页码:138 / 147
页数:10
相关论文
共 38 条
[11]   The case for early detection [J].
Etzioni, R ;
Urban, N ;
Ramsey, S ;
McIntosh, M ;
Schwartz, S ;
Reid, B ;
Radich, J ;
Anderson, G ;
Hartwell, L .
NATURE REVIEWS CANCER, 2003, 3 (04) :243-252
[12]  
Garcia Bradley H 2nd, 2007, J Biomol Tech, V18, P245
[13]   Microarrayed allergen molecules:: diagnostic gatekeepers for allergy treatment [J].
Hiller, R ;
Laffer, S ;
Harwanegg, C ;
Huber, M ;
Schmidt, WM ;
Twardosz, A ;
Barletta, B ;
Becker, WM ;
Blaser, K ;
Breiteneder, H ;
Chapman, M ;
Crameri, R ;
Duchêne, M ;
Ferreira, F ;
Fiebig, H ;
Hoffmann-Sommergruber, K ;
King, TP ;
Kleber-Janke, T ;
Kurup, VP ;
Lehrer, SB ;
Lidholm, J ;
Müller, U ;
Pini, C ;
Reese, G ;
Scheiner, O ;
Scheynius, A ;
Shen, HD ;
Spitzauer, S ;
Suck, R ;
Swoboda, I ;
Thomas, W ;
Tinghino, R ;
Van Hage-Hamsten, M ;
Virtanen, T ;
Kraft, D ;
Müller, MW ;
Valenta, R .
FASEB JOURNAL, 2002, 16 (01) :414-+
[14]   An array of possibilities in cancer research using cytokine antibody arrays [J].
Huang, Ruo-Pan .
EXPERT REVIEW OF PROTEOMICS, 2007, 4 (02) :299-308
[15]   Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays [J].
Hudson, Michael E. ;
Pozdnyakova, Irina ;
Haines, Kenneth ;
Mor, Gil ;
Snyder, Michael .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (44) :17494-17499
[16]   Autoantibody profiling for the study and treatment of autoimmune disease [J].
Hueber, W ;
Utz, PJ ;
Steinman, L ;
Robinson, WH .
ARTHRITIS RESEARCH, 2002, 4 (05) :290-295
[17]   Perspective of trastuzumab treatment. [J].
Iwata H. .
Breast Cancer, 2007, 14 (2) :150-155
[18]   Progress and challenges in screening for early detection of ovarian cancer [J].
Jacobs, IJ ;
Menon, U .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :355-366
[19]   Serum microarrays for large scale screening of protein levels [J].
Janzi, M ;
Ödling, J ;
Pan-Hammarström, Q ;
Sundberg, M ;
Lundeberg, J ;
Uhlén, M ;
Hammarström, L ;
Nilsson, P .
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (12) :1942-1947
[20]   Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling [J].
Kuno, A ;
Uchiyama, N ;
Koseki-Kuno, S ;
Ebe, Y ;
Takashima, S ;
Yamada, M ;
Hirabayashi, J .
NATURE METHODS, 2005, 2 (11) :851-856